{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:08:43Z","timestamp":1778713723093,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 114\\u20132314-B-075B-017"],"award-info":[{"award-number":["NSTC 114\\u20132314-B-075B-017"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 114\\u20132314-B-A49 \\u2212075 \\u2212MY3"],"award-info":[{"award-number":["NSTC 114\\u20132314-B-A49 \\u2212075 \\u2212MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["YSVH115-02"],"award-info":[{"award-number":["YSVH115-02"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["YSVH115-05"],"award-info":[{"award-number":["YSVH115-05"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bcp.2026.117923","type":"journal-article","created":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T15:44:14Z","timestamp":1774194254000},"page":"117923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Xaliproden improves diabetic kidney disease through JNK-mediated renal tubular protection"],"prefix":"10.1016","volume":"249","author":[{"given":"Hsin-Jou","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hung","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szu-Chi","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Wei","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Chu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4116-7029","authenticated-orcid":false,"given":"Ting-Ting","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.bcp.2026.117923_b0005","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic Kidney Disease: challenges, Progress, and Possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.bcp.2026.117923_b0010","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4093\/dmj.2023.0310","article-title":"2023 Diabetic Kidney Disease Fact Sheet in Korea","volume":"48","author":"Kim","year":"2024","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.bcp.2026.117923_b0015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.12659\/MSM.883949","article-title":"Direct renin inhibition\u2013a promising strategy for renal protection?","volume":"19","author":"Lizakowski","year":"2013","journal-title":"Medical Science Monitor : International Medical Journal of Experimental and Clinical Research"},{"issue":"11","key":"10.1016\/j.bcp.2026.117923_b0020","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1681\/ASN.2015050473","article-title":"Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy","volume":"27","author":"Scheele","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.bcp.2026.117923_b0025","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1111\/jdi.13895","article-title":"Current status of diabetic kidney disease and latest trends in management","volume":"13","author":"Kim","year":"2022","journal-title":"J Diabetes Investig"},{"issue":"23","key":"10.1016\/j.bcp.2026.117923_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12237349","article-title":"Pathomechanisms of Diabetic Kidney Disease","volume":"12","author":"Sinha","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bcp.2026.117923_b0035","article-title":"A Glimpse of Inflammation and Anti-Inflammation Therapy in Diabetic Kidney Disease","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2026.117923_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1232790","article-title":"Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms","volume":"14","author":"Xu","year":"2023","journal-title":"Front Endocrinol (lausanne)"},{"key":"10.1016\/j.bcp.2026.117923_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114252","article-title":"Diabetic nephropathy: focusing on pathological signals, clinical treatment, and dietary regulation","volume":"159","author":"Hu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.117923_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1185317","article-title":"Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols","volume":"14","author":"Jin","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.117923_b0055","article-title":"Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol (lausanne)"},{"issue":"1","key":"10.1016\/j.bcp.2026.117923_b0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.tem.2012.09.002","article-title":"Renal progenitors in non-diabetic and diabetic nephropathies","volume":"24","author":"Romagnani","year":"2013","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.bcp.2026.117923_b0065","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12964-023-01323-w","article-title":"Cellular crosstalk of mesangial cells and tubular epithelial cells in diabetic kidney disease","volume":"21","author":"Jiang","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"11","key":"10.1016\/j.bcp.2026.117923_b0070","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1517\/13543780903329089","article-title":"SR 57746A\/xaliproden, a non-peptide neurotrophic compound: prospects and constraints for the treatment of nervous system diseases","volume":"18","author":"Porzner","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bcp.2026.117923_b0075","doi-asserted-by":"crossref","first-page":"10387","DOI":"10.2147\/IJN.S477011","article-title":"The Xaliproden Nanoscale Zirconium-Porphyrin Metal-Organic Framework (XAL-NPMOF) Promotes Photoreceptor Regeneration following Oxidative and Inflammatory Insults","volume":"19","author":"Wang","year":"2024","journal-title":"Int. J. Nanomedicine"},{"issue":"3","key":"10.1016\/j.bcp.2026.117923_b0080","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/ibd\/izab191","article-title":"The Selective 5-HT1A Agonist SR57746A Protects Intestinal Epithelial Cells and Enteric Glia Cells and Promotes Mucosal Recovery in Experimental Colitis","volume":"28","author":"Walldorf","year":"2022","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bcp.2026.117923_b0085","first-page":"294","article-title":"Repurposing an orally available drug for the treatment of geographic atrophy","volume":"22","author":"Ahmed","year":"2016","journal-title":"Mol. Vis."},{"issue":"2","key":"10.1016\/j.bcp.2026.117923_b0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/14660820410019602","article-title":"Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials","volume":"5","author":"Meininger","year":"2004","journal-title":"Amyotroph. Lateral Scler. Other Motor Neuron Disord."},{"issue":"5","key":"10.1016\/j.bcp.2026.117923_b0095","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jalz.2009.07.038","article-title":"Current Alzheimer's disease clinical trials: methods and placebo outcomes","volume":"5","author":"Schneider","year":"2009","journal-title":"Alzheimers Dement."},{"issue":"11","key":"10.1016\/j.bcp.2026.117923_b0100","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.ejca.2008.04.018","article-title":"Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies","volume":"44","author":"Wolf","year":"2008","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.bcp.2026.117923_b0105","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2337\/db21-1079","article-title":"Independent of Renox, NOX5 Promotes Renal Inflammation and Fibrosis in Diabetes by Activating ROS-Sensitive Pathways","volume":"71","author":"Jha","year":"2022","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.bcp.2026.117923_b0110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","article-title":"Signaling pathways of chronic kidney diseases, implications for therapeutics","volume":"7","author":"Yuan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2026.117923_b0115","doi-asserted-by":"crossref","first-page":"e3596","DOI":"10.1002\/dmrr.3596","article-title":"Role of renal tubular programed cell death in diabetic kidney disease","volume":"39","author":"Zhou","year":"2023","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.bcp.2026.117923_b0120","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3389\/fphys.2020.01074","article-title":"GADD45B Promotes Glucose-Induced Renal Tubular Epithelial-Mesenchymal transition and Apoptosis via the p38 MAPK and JNK Signaling Pathways","volume":"11","author":"Xue","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2026.117923_b0125","article-title":"Targeting NK-1R attenuates renal fibrosis via modulating inflammatory responses and cell fate in chronic kidney disease","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2026.117923_b0130","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41401-019-0314-9","article-title":"Prostaglandin E1 attenuates high glucose-induced apoptosis in proximal renal tubular cells by inhibiting the JNK\/Bim pathway","volume":"41","author":"Zhang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.bcp.2026.117923_b0135","article-title":"Oxidative stress: a Culprit in the Progression of Diabetic Kidney Disease","volume":"13","author":"Wang","year":"2024","journal-title":"Antioxidants (basel)"},{"key":"10.1016\/j.bcp.2026.117923_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.116015","article-title":"Downregulation of PDZK1 by TGF-beta1 promotes renal fibrosis via inducing epithelial-mesenchymal transition of renal tubular cells","volume":"220","author":"Lu","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2026.117923_b0145","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1681\/ASN.2006060604","article-title":"A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis","volume":"18","author":"Ma","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"6345","key":"10.1016\/j.bcp.2026.117923_b0150","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/353670a0","article-title":"Phosphorylation of c-jun mediated by MAP kinases","volume":"353","author":"Pulverer","year":"1991","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.bcp.2026.117923_b0155","doi-asserted-by":"crossref","DOI":"10.3390\/cells11193001","article-title":"Macrophages, Chronic Inflammation, and Insulin Resistance","volume":"11","author":"Li","year":"2022","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.bcp.2026.117923_b0160","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2026.117923_b0165","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2119\/2007-00119.Tilg","article-title":"Inflammatory mechanisms in the regulation of insulin resistance","volume":"14","author":"Tilg","year":"2008","journal-title":"Mol. Med."},{"key":"10.1016\/j.bcp.2026.117923_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116899","article-title":"FABP4 inhibition protects renal tubular cells and ameliorates renal inflammation in diabetic kidney disease","volume":"236","author":"Wu","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"4S","key":"10.1016\/j.bcp.2026.117923_b0175","first-page":"S117","article-title":"Disease: improving Global Outcomes, KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","author":"Kidney","year":"2024","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.bcp.2026.117923_b0180","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/14728222.2022.2133698","article-title":"Renal fibrosis as a hallmark of diabetic kidney disease: potential role of targeting transforming growth factor-beta (TGF-beta) and related molecules","volume":"26","author":"Tang","year":"2022","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bcp.2026.117923_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111784","article-title":"Oxidative stress and inflammation in renal fibrosis: Novel molecular mechanisms and therapeutic targets","volume":"421","author":"Liu","year":"2025","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.bcp.2026.117923_b0190","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s00018-024-05532-5","article-title":"Gut microbiota regulates oxidative stress and inflammation: a double-edged sword in renal fibrosis","volume":"81","author":"Li","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2026.117923_b0195","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2023.07.014","article-title":"Oxidative stress and inflammation are mediated via aryl hydrocarbon receptor signalling in idiopathic membranous nephropathy","volume":"207","author":"Wang","year":"2023","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.bcp.2026.117923_b0200","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.7150\/ijbs.93598","article-title":"Chk2 Modulates Bmi1-Deficiency-Induced Renal Aging and Fibrosis via Oxidative stress, DNA damage, and p53\/TGFbeta1-Induced Epithelial-Mesenchymal transition","volume":"20","author":"Lu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"9","key":"10.1016\/j.bcp.2026.117923_b0205","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1038\/s41401-025-01546-2","article-title":"JOSD2 alleviates acute kidney injury through deubiquitinating SIRT7 and negativity regulating SIRT7-NF-kappaB inflammatory pathway in renal tubular epithelial cells","volume":"46","author":"Zhao","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"issue":"12","key":"10.1016\/j.bcp.2026.117923_b0210","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.7150\/ijbs.115364","article-title":"Targeting NINJ1-Mediated Plasma Membrane Rupture in Tubular Epithelial Cell Prevents Inflammatory Response in Acute Kidney Injury","volume":"21","author":"Zhou","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bcp.2026.117923_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101861","article-title":"Deciphering the role of lipoproteins and lipid metabolic alterations in ageing and ageing-associated renal fibrosis","volume":"85","author":"Liu","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"11","key":"10.1016\/j.bcp.2026.117923_b0220","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1038\/s41401-022-00914-6","article-title":"Intrarenal 1-methoxypyrene, an aryl hydrocarbon receptor agonist, mediates progressive tubulointerstitial fibrosis in mice","volume":"43","author":"Cao","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.bcp.2026.117923_b0225","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41401-023-01216-1","article-title":"DsbA-L ameliorates renal aging and renal fibrosis by maintaining mitochondrial homeostasis","volume":"45","author":"Yang","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.bcp.2026.117923_b0230","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41401-024-01363-z","article-title":"USP11 promotes renal tubular cell pyroptosis and fibrosis in UUO mice via inhibiting KLF4 ubiquitin degradation","volume":"46","author":"Wang","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.bcp.2026.117923_b0235","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/IMNA-D-24-00051","article-title":"Therapeutic Effects of Quercetin on Renal Fibrosis and Injury","volume":"12","author":"Wang","year":"2025","journal-title":"Integrative Medicine in Nephrology and Andrology"},{"issue":"6","key":"10.1016\/j.bcp.2026.117923_b0240","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.70075","article-title":"Finerenone in Chronic Kidney Disease: a Comprehensive Review of Mechanisms, Efficacy and Safety","volume":"41","author":"Hu","year":"2025","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"23","key":"10.1016\/j.bcp.2026.117923_b0245","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bcp.2026.117923_b0250","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/jama.2015.10081","article-title":"Mineralocorticoid Receptor Antagonist Tolerability Study-Diabetic Nephropathy Study, effect of Finerenone on Albuminuria in patients with Diabetic Nephropathy: a Randomized Clinical Trial","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.bcp.2026.117923_b0255","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Investigators, Dapagliflozin in patients with Chronic Kidney Disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.117923_b0260","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with Chronic Kidney Disease","volume":"388","author":"The","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bcp.2026.117923_b0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25094959","article-title":"SGLT2 Inhibitors in Kidney Diseases-a Narrative Review","volume":"25","author":"Gajewska","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.117923_b0270","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.drudis.2020.05.004","article-title":"Rodent models of diabetic kidney disease: human translatability and preclinical validity","volume":"26","author":"Sembach","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.bcp.2026.117923_b0275","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2215\/CJN.05150418","article-title":"Clinical Pharmacokinetics in Kidney Disease: Application to Rational Design of Dosing Regimens","volume":"13","author":"Roberts","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522600256X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522600256X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:16:04Z","timestamp":1778710564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522600256X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":55,"alternative-id":["S000629522600256X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117923","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Xaliproden improves diabetic kidney disease through JNK-mediated renal tubular protection","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117923","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117923"}}